These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 38085392)

  • 1. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
    Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
    Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
    Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
    BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term outcome of nephron-sparing surgery versus radical nephroureterectomy for organ-localized upper urinary tract urothelial carcinoma: a population-based study of 1969 patients.
    Qiu J; Deng R; Yu C; Gong K
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14869-14878. PubMed ID: 37598342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
    Massari M; O'Malley P; Benidir T; Su LM; Gao H; Crispen PL
    Urol Oncol; 2024 Sep; 42(9):289.e7-289.e12. PubMed ID: 38802293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is bladder preservation safe? The oncology outcomes of patients after 2-sided radical nephroureterectomies due to bilateral upper urinary tract urothelial carcinomas.
    Kao YL; Yang WH; Ou CH
    Int Urol Nephrol; 2022 Jan; 54(1):63-69. PubMed ID: 34783981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
    Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
    World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value.
    Lai S; Wu P; Liu S; Seery S; Liu J; He L; Liu M; Zhang Y; Wang JY; Xu T
    BMC Urol; 2022 Dec; 22(1):211. PubMed ID: 36566200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
    Guo RQ; Hong P; Xiong GY; Zhang L; Fang D; Li XS; Zhang K; Zhou LQ
    BJU Int; 2018 Feb; 121(2):184-193. PubMed ID: 29032580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
    World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study.
    Ślusarczyk A; Zapała P; Zapała Ł; Rajwa P; Moschini M; Laukhtina E; Radziszewski P
    Urol Oncol; 2024 Jan; 42(1):22.e1-22.e11. PubMed ID: 37981503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    İzol V; Deger M; Ozden E; Bolat D; Argun B; Baltaci S; Celik O; Akgul HM; Tinay İ; Bayazit Y;
    Urol Int; 2021; 105(3-4):291-297. PubMed ID: 33264798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
    Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N
    Eur Urol Oncol; 2024 Oct; 7(5):1061-1068. PubMed ID: 38262800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
    Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
    Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney-Sparing Surgery Has Equivalent Oncological Outcomes to Radical Nephroureterectomy for Ureteral Urothelial Carcinoma.
    Liu K; Zhao H; Ng CF; Teoh JYC; Laguna P; de la Rosette J
    J Endourol; 2024 Sep; 38(9):921-928. PubMed ID: 38756081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.